Artivion price target raised to $32 from $30 at Lake Street

Lake Street analyst Frank Takkinen raised the firm’s price target on Artivion to $32 from $30 and keeps a Buy rating on the shares. The firm thinks the durability of the core business growing mid-to-high single digits with leverage, complemented by significant growth and GM expansion opportunity from Stents, will “continue to resonate with investors.”